Amalgamated Bank Purchases 1,458 Shares of Oscar Health, Inc. (NYSE:OSCR)

Amalgamated Bank grew its stake in Oscar Health, Inc. (NYSE:OSCR) by 27.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,727 shares of the company’s stock after acquiring an additional 1,458 shares during the quarter. Amalgamated Bank’s holdings in Oscar Health were worth $106,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Renaissance Technologies LLC grew its stake in shares of Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after purchasing an additional 934,600 shares during the period. WINTON GROUP Ltd purchased a new position in shares of Oscar Health during the second quarter valued at about $1,363,000. Thoroughbred Financial Services LLC bought a new stake in shares of Oscar Health in the second quarter worth about $402,000. Jupiter Asset Management Ltd. grew its holdings in Oscar Health by 1,179.5% during the 2nd quarter. Jupiter Asset Management Ltd. now owns 562,049 shares of the company’s stock valued at $8,892,000 after buying an additional 518,121 shares in the last quarter. Finally, AGF Management Ltd. purchased a new stake in Oscar Health during the second quarter valued at approximately $4,472,000. Institutional investors own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Piper Sandler restated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. Wells Fargo & Company lifted their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 12th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $24.17.

Insider Transactions at Oscar Health

In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the transaction, the executive vice president now directly owns 392,607 shares of the company’s stock, valued at $6,697,875.42. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, EVP Alessandrea C. Quane sold 16,793 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $286,488.58. Following the sale, the executive vice president now owns 392,607 shares of the company’s stock, valued at approximately $6,697,875.42. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Richard Scott Blackley sold 68,978 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22. Following the transaction, the chief financial officer now owns 884,213 shares of the company’s stock, valued at approximately $15,906,991.87. The disclosure for this sale can be found here. Insiders have sold a total of 169,569 shares of company stock valued at $3,007,069 in the last ninety days. 25.11% of the stock is currently owned by company insiders.

Oscar Health Stock Performance

Shares of NYSE:OSCR opened at $20.63 on Wednesday. The firm has a market capitalization of $4.89 billion, a PE ratio of -51.58, a P/E/G ratio of 43.01 and a beta of 1.61. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. Oscar Health, Inc. has a 1 year low of $4.72 and a 1 year high of $23.79. The business’s 50 day moving average price is $18.70 and its 200-day moving average price is $17.93.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same quarter last year, the company earned ($0.07) earnings per share. The firm’s revenue for the quarter was up 44.6% on a year-over-year basis. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.